Lucid Diagnostics Inc. 8-K

What Happened

• Lucid Diagnostics Inc. announced its financial results for the fiscal quarter ended March 31, 2026 and provided a business update in a press release issued on May 14, 2026. The company filed an 8-K (Item 2.02) to report these quarterly results and included the press release as Exhibit 99.1.

Key Details

• Date of disclosure: May 14, 2026.
• Reporting period: fiscal quarter ended March 31, 2026 (quarterly results / earnings disclosed in the press release).
• Press release attached to the 8-K as Exhibit 99.1; the filing also includes the Inline XBRL cover page (Exhibit 104).
• The filing includes Regulation FD disclosure (Item 7.01), indicating the information was publicly released.

Why It Matters

• The 8-K signals that Lucid has publicly released its latest quarterly earnings and business update; investors should review the attached press release for revenue, net income/loss, guidance, and operational highlights.
• Because this is an Item 2.02 filing, the information may affect short-term trading and longer-term investor assessments of Lucid’s financial condition and outlook.